Pandemic Pushes Global Resilience to its Limits
In the wake of the COVID-19 pandemic, the world of healthcare has seen a significant shift towards digital innovation, with virtual medicine, or telemedicine, gaining significant traction. This transformation is reflected in the latest issue of the Bio + Health newsletter, which provides updates on the rapid expansion and market growth of virtual care, the impact of COVID-19 as a catalyst, and the benefits and limitations of this new approach.
The global virtual care market is projected to reach a staggering USD 114.85 billion by 2032, growing at a CAGR of about 29.27% between 2025 and 2032. In the U.S., the market is expected to hit USD 39.18 billion by 2032, driven by an aging population, favourable reimbursement policies, and collaborations between healthcare systems and digital health companies.
The pandemic has acted as a major catalyst for the adoption, expansion, and innovation of virtual care technologies. This forced rapid deployment has demonstrated virtual care’s critical role in maintaining healthcare continuity during lockdowns and social distancing, particularly in rural and underserved areas.
While virtual care offers benefits such as real-time consultations, chronic disease management, and remote patient tracking, it also presents challenges. These include difficulties with physical examinations, establishing therapeutic relationships, handling complex mental health or sensitive cases, and concerns around privacy, continuity of care, and equitable access.
Leading medical associations endorse virtual care as a complementary delivery mode, acknowledging its inevitability and patient demand. However, there is concern about fragmentation and inequitable delivery unless virtual care is effectively embedded into broader healthcare systems with concrete policies.
Innovations continue, with artificial intelligence increasingly integrated into healthcare workflows, including virtual care documentation, clinical note generation, and administrative simplification. The pandemic's disruptions have also extended to medical education, pushing a shift towards virtual and hybrid clinical training models.
It's important to note that any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in the content are subject to change without notice and may differ or be contrary to opinions expressed by others. Investments made by funds managed by our website are not representative of all investments in vehicles managed by our website.
Readers can sign up for the Bio + Health newsletter to stay informed about the latest insights on the future of biology, technology, and care delivery. The newsletter also provides updates on COVID-19, virtual medicine, diagnostic tests, and more.
[1] Savitskaya, J., & Conde, J. (2021). Testing Times: Active Infections vs. Immunity. [Blog post] [2] Yoo, J., Pande, V., & Tidnam, H. (2021). Opportunities and Limitations of Virtual Medicine. [Podcast discussion] [3] King, D. (2021). Integrating New Tests and Technologies. [Podcast with Dave King] [4] 16 Minutes. (2021). Discussing the Rules: Julie Yoo, Venkat Mocherla, and Sonal Chokshi. [News show episode] [5] Our Website. (2021). Launching the Biotech Ecosystem Fund in Partnership with Lilly. [Press release] [6] Our Website. (2021). Coronavirus Resources & Readings. [List of resources]
The global shift towards digital innovation in healthcare, driven by telemedicine, is projected to significantly grow the virtual care market, reaching USD 114.85 billion by 2032. This growth is attributed to factors such as an aging population, favorable reimbursement policies, and collaborations between healthcare systems and digital health companies.
While virtual care offers benefits for managing chronic diseases and providing real-time consultations, it also presents challenges, such as difficulties with physical examinations, establishing therapeutic relationships, and concerns around privacy and equitable access. TheRole of science in addressing these challenges is crucial, particularly in developing innovative solutions like artificial intelligence for virtual care documentation and clinical note generation.